.jpg?format=webp&width=780)
The study aimed to evaluate the efficacy of CO2 intravaginal laser therapy in the treatment of stress urinary incontinence (SUI) in patients waiting for anti-incontinence surgery. Fifty-two patients were divided into two groups: atrophy and no atrophy. A control group retrospectively identified from the database of patients undergoing pelvic floor muscle training (PFMT) was also included. The results showed that the intravaginal CO2 laser improved all the parameters considered for SUI in both groups, with more significant results in the atrophy group. The laser therapy was well-tolerated, minimally invasive, safe, and showed efficacy for SUI. Further studies are needed to consider it as first-instance therapy or at least as a bridge therapy to surgery, like PFMT.
Like
Save
Share